C
Genfit S.A. GNFT
$4.75 $0.224.86% NASDAQ
Recommendation
Prev Close
$4.53
Volume
5,865
Avg Vol (90D)
11,178
Market Cap
$228.00M
Dividend & Yield
--
52-Week Range
$2.55 - $6.42
P/E (TTM)
11.39
EPS (TTM)
$0.3978
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
GENFIT Highlights ACLF Research at EASL Congress 2025
5/5/2025 - TipRanks Financial Blog
GENFIT Releases 2024 Annual Reports, Enhancing Transparency
4/29/2025 - TipRanks Financial Blog
Genfit (GNFTF) Gets a Buy from Kepler Capital
4/27/2025 - TipRanks Financial Blog
Genfit (NASDAQ:GNFT) Stock Price Up 2.1% - What's Next?
4/16/2025 - MarketBeat
Genfit (NASDAQ:GNFT) Stock Price Down 2.8% - Time to Sell?
3/26/2025 - MarketBeat
Kepler Capital Sticks to Its Buy Rating for Genfit (GNFTF)
3/13/2025 - TipRanks Financial Blog
Genfit S.A. (NASDAQ:GNFT) Short Interest Down 40.5% in February
3/4/2025 - Ticker Report
Short Interest in Genfit S.A. (NASDAQ:GNFT) Declines By 40.5%
3/2/2025 - MarketBeat
Genfit (NASDAQ:GNFT) Shares Down 2% - Time to Sell?
3/2/2025 - MarketBeat
Analysts' Top Healthcare Picks: Genfit (GNFTF), Ventyx Biosciences (VTYX)
3/2/2025 - TipRanks Financial Blog
Kepler Capital Sticks to Its Buy Rating for Genfit (GNFTF)
2/23/2025 - TipRanks Financial Blog
Genfit (NASDAQ:GNFT) & Omega Therapeutics (NASDAQ:OMGA) Critical Analysis
2/20/2025 - Ticker Report
Genfit S.A. (NASDAQ:GNFT) Sees Large Increase in Short Interest
2/17/2025 - MarketBeat
GENFIT Amends Terms of 2025 OCEANEs Proposal Amid Royalty Financing
2/14/2025 - TipRanks Financial Blog
Genfit (GNFTF) Gets a Buy from Kepler Capital
2/14/2025 - TipRanks Financial Blog
GENFIT Finalizes 2025 Bond Repurchase Terms Amidst Royalty Financing Deal
2/10/2025 - TipRanks Financial Blog
Genfit announces final terms for dual proposal to 2025 Oceanes holders
2/10/2025 - TipRanks Financial Blog
Genfit announces final terms for dual proposal to 2025 Oceanes holders
2/10/2025 - The Fly
Kepler Capital Reaffirms Their Buy Rating on Genfit (GNFTF)
2/9/2025 - TipRanks Financial Blog
FY2024 EPS Estimates for Genfit Reduced by Leerink Partnrs
2/6/2025 - MarketBeat
Genfit S.A. (NASDAQ:GNFT) Sees Large Growth in Short Interest
2/4/2025 - Ticker Report
Genfit SA (GNFT) Receives a Rating Update from a Top Analyst
2/3/2025 - TipRanks Financial Blog
Genfit S.A. (NASDAQ:GNFT) Sees Large Increase in Short Interest
2/3/2025 - MarketBeat
Kepler Capital Sticks to Its Buy Rating for Genfit (GNFTF)
2/1/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$87.02M
EBITDA (TTM)
$23.64M
EBIT (TTM)
$21.87M
Net Income (TTM)
$24.06M
Balance Sheet
Total Assets (Q)
$208.70M
Total Debt (Q)
$72.65M
Total Liabilities (Q)
$104.38M
Book Value Per Share (Q)
$2.10
Cash Flow
Cash from Operations (TTM)
-$44.95M
Cash from Investing (TTM)
-$1.23M
Cash from Financing (TTM)
-$8.18M
Net Change in Cash (TTM)
-$54.30M
Filings
Filing Date
Thursday, September 19, 2024
Period Date
Sunday, June 30, 2024
Next Filing
(est)
Price History
Loading...
Beta
1.18
7-Day Total Return
30.49%
30-Day Total Return
34.56%
60-Day Total Return
21.48%
90-Day Total Return
24.35%
Year to Date Total Return
24.02%
1-Year Total Return
34.56%
2-Year Total Return
11.19%
3-Year Total Return
38.89%
5-Year Total Return
-77.35%
52-week Low
Apr 09, 2025 - $2.55
52-week High
Oct 17, 2024 - $6.42
Valuation
Market Cap
$228.00M - Micro Cap
Enterprise Value
$205.73M
Price/Sales (TTM)
3.14
Price/Book (Q)
2.16
Dividends and Shares
Shares Outstanding
60.36M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.genfit.com
Phone Number
33 3 20 16 40 00
Address
Parc EurasantE
Loos, 59120
Country
France
Year Founded
1999
Business Description
Sector
--
Industry
--
Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor... more
NASDAQ 05/06/2025 10:58AM Eastern Quotes delayed